Stocks
Arena Pharmaceuticals, Inc.ARNA
NASDAQHealthcareBiotechnology$99.99+0.00%
A biotechnology company focused on developing small‑molecule drugs for immuno‑inflammatory diseases, including treatments targeting conditions such as ulcerative colitis and other autoimmune disorders. Its pipeline of clinical-stage therapies drew significant investor attention in the biotech sector...
Market Cap: $052W Range: $45.50 – $100.00
Congressional Interest in Arena Pharmaceuticals, Inc. (ARNA)
4 members of Congress have disclosed 11 trades in Arena Pharmaceuticals, Inc. (ARNA), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 8 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
11
Unique Politicians
4
Buys
3
Sells
8
Who in Congress Is Trading ARNA?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-02-12 | John A. Yarmuth | buy | $1K – $15K |
| 2020-11-20 | Thomas R Carper | buy | $1K – $15K |